It is noteworthy that since NRF2-driven alterations of cancer metabolism and growth are frequently found in malignant tumors of different origin, the strong dependence on this signaling pathway, especially in NRF2-addicted cancer cells, can also reveal specific vulnerabilities that might be therapeutically exploited. This evidence concerns the gene NFE2L2 and cancer.